Intellectual property strategy for an Indian startup is not a luxury — it is a financing instrument, a competitive moat, and increasingly a due diligence item for investors. Yet the Indian patent system, shaped by the Patents Act 1970 and significant judicial interpretation, operates differently from the US and European frameworks that most founders encounter first.
Understanding what India will and will not protect, before committing resources to prosecution, is foundational.
## What Is Patentable in India
The Patents Act 1970 sets out the basic requirements at Section 2(1)(j): an "invention" must be a new product or process involving an inventive step and capable of industrial application.
The three requirements are:
**Novelty**: The invention must not form part of the prior art — i.e., it must not have been disclosed anywhere in the world before the priority date. A single prior art reference that anticipates all the claims of your application kills novelty completely.
**Inventive step**: The invention must not be obvious to a person skilled in the art. This is not a low bar — the Indian Patent Office applies this test strictly, and many applications fail at this stage even where novelty is established.
**Industrial application**: The invention must be capable of being made or used in some kind of industry. This is rarely a barrier for technology and product inventions.
## Section 3: What Cannot Be Patented
Section 3 of the Patents Act lists categories of subject matter that are not inventions for the purposes of the Act. For startups, three exclusions are critical:
**Section 3(k) — Mathematical methods, business methods, algorithms, and computer programmes per se**: This is the provision that most affects technology startups. Indian patent law does not protect:
- Pure algorithms
- Mathematical methods
- Business methods
- Computer programmes "per se"
The phrase "per se" has generated enormous litigation and examination controversy. The Indian Patent Office's revised guidelines (2017, amended 2019) attempt to clarify that a computer-implemented invention — one where software produces a technical effect on hardware — may be patentable, but a software application that merely processes data without producing a technical effect outside the computer is not.
The practical result: a purely software-as-a-service product is unlikely to be patentable in India. An invention that uses software to control physical hardware, or that produces a demonstrably technical improvement (reduced memory usage, faster processing through a novel algorithmic architecture applied to specific hardware constraints), has a stronger case.
**Section 3(d) — Enhanced forms of known substances**: This provision, best known from pharmaceutical litigation, prevents patents on new forms (salts, polymorphs, dosages) of known molecules without demonstrated enhanced efficacy. Biotech and pharmaceutical startups must structure their claims carefully to avoid this exclusion.
**Section 3(p) — Traditional knowledge**: Inventions that are anticipated by traditional knowledge or that aggregate traditional knowledge components are excluded.
## Software Patents: Navigating Section 3(k)
For a startup with a software product, the strategy is:
1. **Frame claims around technical effect**: Draft claims that emphasise the technical improvement achieved — reduced latency, improved hardware efficiency, novel signal processing. The technical effect must be real and demonstrable, not asserted.
2. **System claims over method claims**: A system claim (a computer comprising processors configured to...) can sometimes succeed where a method claim (a method comprising steps of...) fails under 3(k). The distinction is not entirely logical but reflects examination practice.
3. **Involve hardware elements**: An invention that requires specific hardware interaction — sensors, actuators, novel network architecture — is better positioned than pure software.
4. **Expect examination objections**: Most software applications receive a Section 3(k) objection at examination. This is not fatal — it requires a substantive response demonstrating technical effect with evidence if necessary.
## PCT vs Indian Patent Application: The Strategic Choice
Startups almost always face this decision: file a national Indian application first, or enter the Patent Cooperation Treaty route?
**Indian national application** (direct filing at the Indian Patent Office):
- Cheaper upfront (official fees, translation costs avoided)
- Establishes a priority date in India immediately
- Must be prosecuted in India; does not automatically provide protection elsewhere
- Examination timeframe: 3–6 years from filing to grant (expedited examination available for startups and certain categories)
**PCT application**:
- Files through WIPO, establishing a single international priority date
- The international phase (18–30 months) defers national phase entry in each country, buying time to assess commercial value before committing to prosecution costs in multiple jurisdictions
- National phase entry in India requires a translation (if filed in another language) and the standard Indian examination process
- For a startup seeking global protection or likely to raise international investment, PCT is the sensible route
**The expedited examination route**: India introduced expedited examination under Rule 24C for startups recognised by DPIIT under the Startup India initiative. Examination commences within 1 month of the request, compared to the standard queue of 2–5 years. This is a material advantage — a granted patent within 18–24 months from filing is achievable for a DPIIT-recognised startup.
## Timeline and Cost Estimates
A realistic cost projection for an Indian patent:
| Stage | Timeline | Estimated Cost (INR) |
|---|---|---|
| Prior art search + opinion | 2–4 weeks | 25,000–50,000 |
| Application drafting + filing | 4–8 weeks | 50,000–1,20,000 |
| First examination report response | 12–18 months after filing | 30,000–80,000 |
| Grant | 2–5 years from filing | — |
| Total (single application) | — | 1,50,000–3,00,000 |
Annual renewal fees commence from the third year of filing.
For PCT applications, add WIPO international filing fees (~$1,500–2,500) and national phase entry costs in each country (~$3,000–7,000 per jurisdiction including local counsel).
## Pre-Filing Confidentiality Is Critical
A disclosure before filing destroys novelty globally. Every startup must implement:
- **NDAs before any technical disclosure** to investors, partners, or customers
- **Grace period caution**: India has a limited 12-month grace period under Section 31 for disclosures at specified exhibitions and government bodies — it does not extend to general investor pitches or publications
- **Employee invention assignment agreements**: Ensure employment contracts assign all inventions made in the course of employment to the company
The founders' tendency to present at conferences, publish blog posts, and share decks before filing a provisional application has killed more Indian startup patent applications than examination rejections.
## Building a Patent Portfolio
A single patent rarely creates a durable competitive advantage. Investors and acquirers look for:
- Claim breadth — does the portfolio cover the core technology and design-around variants?
- Prosecution history — are the claims well-maintained or have they been narrowed into irrelevance by prior art citations?
- Geographic spread — key markets covered?
- Continuation strategy — are follow-on applications being filed to capture product development?
For most startups, a patent portfolio of 3–8 granted or pending applications, well-aligned with the core product architecture, is more valuable than a single broad grant.
Corpus Juris Legal's Intellectual Property practice advises Indian startups on patent strategy from pre-filing through prosecution, licensing, and portfolio management. If you are evaluating whether your technology merits patent protection in India or internationally, begin with a structured patentability analysis before committing to filing costs.
PatentStartup IndiaSection 3(k)PCTIntellectual PropertyDPIIT
AP
Adv. Priya Mehta
Partner, Corpus Juris Legal
Corporate counsel advising clients across M&A, regulatory compliance, and dispute resolution. Committed to precise, partner-led legal work.
Have a related legal question?
Speak with a specialist partner. Free initial consultation.
Request Consultation